Abstract
Receptors attached to the G (GPCRs) protein have shown themselves to be an interesting therapeutic target. Thirty-nine of the 100 most commonly used drugs in clinics act directly or indirectly through the activation or blocking of receptors of the GPCRs (Menzaghi et al. 2002) type. The production of antibodies which recognize a specific conformation of GPCRs (active or inactive) represent…
